Eli Lilly's Weight Loss Drug Zepbound Cuts Sleep Apnea Severity in Late-Stage Studies

Retrieved on: 2024-04-17 18:16:26

Tags for this article:

Click the tags to see associated articles and topics

Eli Lilly's Weight Loss Drug Zepbound Cuts Sleep Apnea Severity in Late-Stage Studies. View article details on hiswai:

Excerpt

Zepbound lowered sleep apnea severity by up to nearly two-thirds in obese adults, with and without PAP therapy, in two phase 3 trials.

Article found on: sleepreviewmag.com